Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study

NCT05491616 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
77
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Erasmus Medical Center